Blood eosinophils were activated with IL-3 (2ng/ml), IL-5 (4ng/ml) or GM-CSF (2ng/ml), or cultured without cytokine (Resting) for 20 h and then stained for flow cytometric analysis. PE-conjugated anti-CD32 (FCGRII) (clone FUN-2) was from Biolegend (San Diego, CA), FITC-conjugated anti-CD64 (FCGRI-clone 10.1), FITC-conjugated anti-CD16 (FCGRIII-clone 3G8), PE-conjugated anti CD11b (αM-clone D12), FITC-conjugated anti-CD18 (ß2-clone L130) and corresponding isotype controls, PE- and FITC-conjugated mouse IgG1 were all from BD Biosciences. The activation state of CD32 was measured using the previously described monoclonal phage antibody A17 [34 (link), 35 (link)]. Activation-sensitive anti-αM CBRM1/5 was from BioLegend and anti-β1 N29, from Chemicon/Millipore/Sigma-Aldrich [36 (link)]. PE-conjugated goat anti-mouse Ab was used as the secondary Ab. Five to 10 thousand viable (no propidium iodide uptake) cells were acquired on a FACSCalibur (BD Biosciences). Data were analyzed with FlowJo (TreeStar Inc., Ashland, OR).